91 related articles for article (PubMed ID: 12415200)
1. Towards defining specific antigens for cutaneous lymphomas.
Eichmüller S
Onkologie; 2002 Oct; 25(5):448-54. PubMed ID: 12415200
[TBL] [Abstract][Full Text] [Related]
2. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity.
Eichmüller S; Usener D; Thiel D; Schadendorf D
Int J Cancer; 2003 Apr; 104(4):482-7. PubMed ID: 12584747
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
4. [Epidermotropic T cell lymphomas as models for tumor progression].
Bagot M; Bensussan A
Med Sci (Paris); 2006 Feb; 22(2):192-6. PubMed ID: 16457762
[TBL] [Abstract][Full Text] [Related]
5. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma.
Hartmann TB; Thiel D; Dummer R; Schadendorf D; Eichmüller S
Br J Dermatol; 2004 Feb; 150(2):252-8. PubMed ID: 14996095
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
7. cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.
Usener D; Schadendorf D; Koch J; Dübel S; Eichmüller S
J Invest Dermatol; 2003 Jul; 121(1):198-206. PubMed ID: 12839582
[TBL] [Abstract][Full Text] [Related]
8. A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma.
Linnemann T; Wiesmüller KH; Gellrich S; Kaltoft K; Sterry W; Walden P
Ann Oncol; 2000; 11 Suppl 1():95-9. PubMed ID: 10707788
[TBL] [Abstract][Full Text] [Related]
9. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions.
Kempf W; Dummer R; Burg G
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473
[TBL] [Abstract][Full Text] [Related]
10. Immunoscreening of a cutaneous T-cell lymphoma library for plasma membrane proteins.
Lee M; Kistler C; Hartmann TB; Li F; Dummer R; Dippel E; Booken N; Klemke CD; Schadendorf D; Eichmüller SB
Cancer Immunol Immunother; 2007 Jun; 56(6):783-95. PubMed ID: 17089123
[TBL] [Abstract][Full Text] [Related]
11. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
Bolli M; Schultz-Thater E; Zajac P; Guller U; Feder C; Sanguedolce F; Carafa V; Terracciano L; Hudolin T; Spagnoli GC; Tornillo L
Int J Cancer; 2005 Jul; 115(6):960-6. PubMed ID: 15751033
[TBL] [Abstract][Full Text] [Related]
12. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lymphomas: an update. Part 1: T-cell and natural killer/t-cell lymphomas and related conditions.
Kempf W; Kazakov DV; Kerl K
Am J Dermatopathol; 2014 Feb; 36(2):105-23. PubMed ID: 24556897
[TBL] [Abstract][Full Text] [Related]
14. Expression of three cell proliferation-associated antigens, DNA polymerase alpha, Ki-67 antigen and transferrin receptor in nodal and cutaneous T-cell lymphomas.
Mitani S; Tango T; Sonobe Y; Baba N; Nagatani T; Nomoto S; Mori S
Int J Hematol; 1991 Oct; 54(5):385-93. PubMed ID: 1756249
[TBL] [Abstract][Full Text] [Related]
15. Identification of selectively expressed genes and antigens in CTCL.
Hartmann TB; Mattern E; Wiedemann N; van Doorn R; Willemze R; Niikura T; Hildenbrand R; Schadendorf D; Eichmüller SB
Exp Dermatol; 2008 Apr; 17(4):324-34. PubMed ID: 17979976
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope.
Tumenjargal S; Gellrich S; Linnemann T; Muche JM; Lukowsky A; Audring H; Wiesmüller KH; Sterry W; Walden P
Eur J Immunol; 2003 Nov; 33(11):3175-85. PubMed ID: 14579286
[TBL] [Abstract][Full Text] [Related]
17. Experimental treatment strategies in primary cutaneous T-cell lymphomas.
Rozati S; Kim YH
Curr Opin Oncol; 2016 Mar; 28(2):166-71. PubMed ID: 26844985
[TBL] [Abstract][Full Text] [Related]
18. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA class I dependent immunogenic peptides from clonotypic TCRbeta expressed in cutaneous T-cell lymphoma.
Zeng J; Müller-Berghaus J; Nguyen XD; Klüter H; Schönhaber H; Song M; Schwinn N; Schadendorf D; Goerdt S; Eichmüller S; Dippel E
Int J Cancer; 2006 Nov; 119(10):2476-80. PubMed ID: 16858680
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
